Abstract
Despite a higher incidence of HPV-related cancer in HIV-positive (HIV+) patients (pts), pivotal studies with curative chemoradiation (CRT) in anal cancer do not include this population. The impact of HIV infection remains unknown in this scenario. This study aimed to compare overall survival (OS) according to HIV status.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
